TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 3 | 3 | 11 | 8 | 55 | 75 | 31 | 31 |
| P | %wins | 100 | 100 | 67 | 67 | 67 | 67 | 78 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/27/10 18:02 | 8/27/10 | AVII | Avi Biopharma Inc | OR | Health | Drug | Pharmaceutical Preparations | Boyle J David II | WA | O | CEO | P | 11 | 2.13 | 4 | 5 | 8 | 70 | D | 85 | 44 | 42 | 43 | 13 | 4 | -1 | 1 | 0 | 1 | -11 | -14 | -6 | -49 |
3/13/09 20:43 | 3/13/09 | AVII | Avi Biopharma Inc | OR | Health | Drug | Pharmaceutical Preparations | Boyle J David II | OR | O | CFO | P.d | 12 | 0.6392 | 0 | 19 | 41 | 65 | 8 | 22 | 10 | 164 | 212 | 122 | |||||||||
8/17/05 18:21 | 8/17/05 | XOMA | Xoma Ltd /de/ | DE | Health | Drug | Pharmaceutical Preparations | Boyle J David II | CA | O | VP,Finan | P | 7 | 1.44 | 0 | 5 | New | 5 | D | -82 | -35 | 9 | 6 | -14 | -11 | -9 | -10 | 2 | 10 | 26 | 14 | 20 | 20 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |